IRVING, Texas, Oct. 19, 2021 /PRNewswire/ -- Darling Ingredients Inc.'s (NYSE: DAR) health brand, Rousselot®, the global leader of collagen-based solutions, today launches Quali-Pure™, a range of gelatins for biomedical applications with controlled endotoxin levels. The latest addition to Rousselot Biomedical's rapidly expanding portfolio, Quali-Pure has been specifically designed for a variety of applications including embolization, wound healing, drug delivery, vaccines and hemostatics. Quali-Pure delivers biocompatibility, biodegradability, controlled endotoxin levels, and batch-to-batch consistency, and fully supports medical device compliance with ISO 22442 and the new EU Medical Device Regulation (MDR) standards.